Streetbeat News

Stock Prices

TSBX

Turnstone Biologics shares are trading lower after the company reported worse-than-expected Q2 EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:25 pm

LVLU

Lulus Fashion Lounge (NASDAQ:LVLU) reported a significant decline in its Q2 2024 financial performance. The company posted a GAAP EPS of $(0.26), a 271.43% decrease from $(0.07) YoY, and sales of $91.97M, missing the $96.46M estimate and down 13.34% from $106.12M YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:25 pm

CELC

Celcuity shares are trading lower following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:25 pm

BNAI

Brand Engagement Network (NASDAQ:BNAI) reported a Q2 EPS loss of $(0.09), an improvement from the $(0.15) loss per share in the same period last year, representing a 40% increase.

Portfolio Pulse from totan@benzinga.com

August 14, 2024 | 8:24 pm

NVGS

Navigator Holdings shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:24 pm

TITN

Titan Machinery shares are trading lower after the company reported preliminary Q2 financial results below estimates.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:24 pm

YCBD

cbdMD (AMEX:YCBD) reported Q3 GAAP EPS of $(0.15), beating the $(0.62) estimate by 75.81%. Sales were $5.17M, surpassing the $4.93M estimate by 4.95%. Despite the positive earnings surprise, sales decreased by 15.44% compared to the same period last year.

Portfolio Pulse from saritha@benzinga.com

August 14, 2024 | 8:24 pm

LITE

Lumentum Holdings shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 revenue guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:23 pm

BFRI

Biofrontera (NASDAQ:BFRI) reported Q2 2024 GAAP EPS of $(0.05) and sales of $7.84 million, missing the analyst estimate of $8.21 million. Despite the miss, sales increased by 34.05% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:22 pm

SSKN

Strata Skin Sciences (NASDAQ:SSKN) reported Q2 2024 GAAP EPS of $(0.03), significantly beating the analyst estimate of $(0.70). The company also reported sales of $8.40 million, surpassing the $7.42 million estimate and showing a 1.82% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 8:22 pm